HIV/Aids Neuropsychiatric Co-Morbidity: Alcohol?s Impact on Cd4 Count In HIV Patients
Received Date: Jan 01, 2024 / Published Date: Jan 31, 2024
Abstract
This article examines the complex interplay between HIV/AIDS, neuropsychiatric co-morbidity, and alcohol use disorder (AUD), with a particular focus on the impact of alcohol consumption on CD4 count in HIV-infected individuals. Neuropsychiatric disorders are prevalent among HIV/AIDS patients, ranging from cognitive impairment to mood and substance use disorders, significantly affecting quality of life and treatment outcomes. Concurrently, AUD is highly prevalent in this population and exacerbates disease progression and treatment challenges. Chronic alcohol consumption adversely affects CD4 T-cell counts, leading to immune dysfunction and increased susceptibility to infections and non-AIDS-related complications. Understanding and addressing the intersection of HIV/AIDS, neuropsychiatric co-morbidity, and alcohol use are essential for optimizing patient care and improving outcomes in this vulnerable population.
Citation: Singh B (2024) HIV/Aids Neuropsychiatric Co-Morbidity: Alcohol’s Impacton Cd4 Count In HIV Patients. J Neuroinfect Dis 15: 483. Doi: 10.4172/2314-7326.1000483
Copyright: © 2024 Singh B. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.
Share This Article
Recommended Journals
黑料网 Journals
Article Tools
Article Usage
- Total views: 394
- [From(publication date): 0-2024 - Mar 13, 2025]
- Breakdown by view type
- HTML page views: 298
- PDF downloads: 96
